Relmada Therapeutics annual net profit margin
2012
2013
Relmada Therapeutics Net Profit Margin Growth & History (RLMD)
Relmada Therapeutics's net profit margin was −877.66% for fiscal 2013.
View full Relmada Therapeutics company overviewRelmada Therapeutics annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2013 · Aug 31 | 2013-08-31 | −877.66% | −725.89 pp |
| 2012 · Aug 31 | 2012-08-31 | −151.77% | — |
Relmada Therapeutics quarterly net profit margin
Q3.12
Q1.13
Q1.13
Q2.13
Q1.14
Q1.14
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q1 2014 · Feb 28 | 2014-02-28 | −458.06% | −281.34 pp |
| Q1 2014 · Nov 30 | 2013-11-30 | −776.97% | −357.24 pp |
| Q2 2013 | 2013-05-31 | −3,073.34% | −2453.09 pp |
| Q1 2013 · Feb 28 | 2013-02-28 | −176.73% | — |
| Q1 2013 · Nov 30 | 2012-11-30 | −419.73% | — |
| Q3 2012 | 2012-05-31 | −620.25% | — |
Relmada Therapeutics net profit margin trends
Between the periods ended 2012-08-31 and 2013-08-31, Relmada Therapeutics's net profit margin decreased from −151.77% to −877.66%, a change of −725.89 percentage points. The latest reported quarter, Q1 2014 · Feb 28, shows −458.06%.
About the metric
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
Calculation and source
How net profit margin is calculated
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Relmada Therapeutics source filings ↗